Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, Week Ending July 12, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Jazz Pharmaceuticals plc Preclinical Pan-RAF inhibitor program $3,500,000 Altimmune Inc. Spitfire Pharma, Inc. $5,000,000 eHealth Acquirer Target Price iMedX, Inc. Prevalent, Inc. and Axcension, Inc. N/A Waystar Digitize.AI N/A Rhapsody... Read More »
Q2:19 Posts Strong Healthcare Deal Volume & Dollars
Second quarter deal volume was robust, based on preliminary results. Some 424 deals are on the books for the quarter, representing an 8% increase over the first quarter (394 deals). It’s still a hard comparison with Q2:18 numbers, which had 484 announcements, 12% higher than this year’s period. Spending remained high in the second quarter, at $138.5 billion, thanks to AbbVie’s (NYSE: ABBV) $87 billion deal for Allergan (NYSE: AGN) announced in late June. Coincidentally, even higher totals were posted in the first quarter and in the second quarter of 2018, also due to mega-deals. In this year’s first quarter, Bristol-Myers Squibb’s (NYSE: BMY) $74 billion deal for Celgene (NASDAQ: CELG) and... Read More »
June Healthcare M&A Busted Out All Over
Healthcare mergers and acquisitions turned in another strong performance in June, on the heels of a busy month in May. Preliminary data shows 138 transactions announced, just 5% below the previous month’s 146 and 7% behind the same month in 2018. The Long-Term Care sector led the way, as usual, with a 23% share of the month’s total deal volume. With 32 deals reported, deal activity wasn’t as strong as it was in May (42 deals), but stayed on par with the 31 deals announced the year before. Two sectors posted big gains, year over year. The Laboratories, MRI & Dialysis sector saw a 600% increase, albeit on only seven deals. The Medical Device sector realized a 56% jump over last year’s... Read More »Digital Health Sector M&A Activity Stays Strong in June
June was a busy month for the digital health sector. Our totals so far are 16 deals, but that number may increase as we find some deals disclosed in quarterly reports. It doesn’t quite reach the count from June 2018 (25 deals), but 2018 was so robust in deal volume it’s a hard comparison to make. In 2017, for instance, there were only 13 deals reported. Dollar volume, on the other hand, is difficult to compare, mainly because of the headline-worthy transaction below. Dassault Systèmes (Paris: DSY) acquired Medidata Solutions, Inc. (NASDAQ: MDSO) for $5.8 billion, the second largest digital health transaction in our database. This acquisition increases Dassault’s services for... Read More »
HCA Healthcare Buys Network of Urgent Care Centers in Texas
HCA Healthcare (NYSE: HCA) announced last week it purchased 24 MedSpring urgent care centers in Texas from Fresenius Medical Care (NYSE: FMS). MedSpring centers offer treatment for a wide range of common injuries and illnesses. The 24 clinics are dispersed throughout major cities like Austin, Dallas and Houston. Fresenius acquired MedSpring Urgent Care Centers in 2014 for an undisclosed price. At the time, the company operated 14 centers, so this most recent deal shows significant growth in the target company. HCA Healthcare now operates a total of 160 centers across the country. The MedSpring centers will be rebranded to CareNow Urgent Care and operated by HCA. This deal comes on the... Read More »
U.S. Hospital M&A Trends, 1H 2019
It’s been a slow year for hospital mergers and acquisitions in the United States. In the first half of 2019, just 29 transactions have reached the definitive agreement stage, or actually closed. In the first half of 2018, 38 transactions made that cut. The targets are much smaller in 2019, too. A total of 4,991 beds changed hands in the first six months of this year, compared with 9,327 beds in the same period in 2018. Fourteen not-for-profit hospitals or systems (2,380 beds combined) were targets in 1H:19, and three of them were critical access hospitals which are regulated to just 25 beds. That’s not a stand-out trend, considering six critical access hospitals found new... Read More »
Health Care M&A Deals, Week Ending July 5, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Zai Lab Limited License for INCMGA0012 $17,500,000 eHealth Acquirer Target Price Carenet Healthcare Services Telehealth subsidiary of Citra Health N/A Net Health Optima Healthcare Solutions N/A Physician Medical Groups Acquirer Target... Read More »
Is Laboratories, MRI and Dialysis on the Rise?
We call the Laboratories, MRI and Dialysis sector our grab-bag sector, and it seldom makes much noise. Diagnostic laboratories, radiology, and dialysis providers comprise this sector. Last year, there were only 48 deals announced, according to our Deal Search Online database, and the first quarter of 2019 reported only 11 deals, a 47% decrease from the same quarter in 2018. It hit a high of 56 deals in 2017. However, the sector seems to have picked up in the second quarter this year. The deal count caught up and we’re now at 24 deals, roughly equal to last year’s pace. But that’s not all. Last year, there was $1.68 billion in announced prices. This year we already have... Read More »
Array BioPharma Grabbed By Pfizer for $11.4 Billion
With AbbVie Inc.’s (NYSE: ABBV) surprise $87 billion bid for Allergan plc (NYSE: AGN) dominating headlines this week, you’d be forgiven for forgetting Pfizer (NYSE: PFE) just bought Array BioPharma (NASDAQ: ARRY) for $11.4 billion only days before. It’s the pharmaceutical giant’s biggest deal of the year thus far in announced dollar volume, and only second behind the aforementioned transaction. The terms included $48 per share in cash, with 237,500,000 shares outstanding, representing a 62% premium to ARRY’s closing price on Friday, June 13. Array BioPharma is a commercial-stage biopharmaceutical company focused on the discovery, development, and... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
